Against the motion: This house believes that hippocampus avoiding WBI is the current standard of care

被引：0

作者：

Le Pechoux, C. ^{[1
]}

Levy, A. ^{[1
]}

Botticella, A. ^{[1
]}

Henry, O. ^{[2
]}

Auzac, G. ^{[2
]}

Bolle, S. ^{[1
]}

Dhermain, F. ^{[1
]}

机构：

[1] Gustave Roussy Canc Campus, Radiat Oncol, Villejuif, France

[2] Gustave Roussy Canc Campus, Radiat Oncol Phys, Villejuif, France

来源：

RADIOTHERAPY AND ONCOLOGY | 2020年 / 152卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

SP-0146

引用

下载

页码：S69 / S69

页数：1

共 9 条

[1] Against the Motion: This house believes that immunotherapy is really changing radiation oncology
Baumann, Michael
Ebert, Nadja
RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S358 - S358
[2] This house believes that larger fraction sizes will be the standard-of-care for the majority of curative treatments by 2025
Yarnold, J. R.
RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S296 - +
[3] Speaker against: This house believes that nurses are able to meet patients' health care needs
Luker, KA
EUROPEAN JOURNAL OF CANCER, 1999, 35 : S49 - S49
[4] This house believes: Combination therapy for intermediate and high-risk pCa represents the best standard of care
Keyes, M.
RADIOTHERAPY AND ONCOLOGY, 2021, 158 : S19 - S20
[5] Against the motion This House believes that patients with Squamous Cell Carcinoma (SCC) of Oesophagus no longer need surgery
Allum, W.
RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S359 - S359
[6] This house believes that short-course radiotherapy is the ideal schedule as part of total neoadjuvant therapy programs for rectal cancer Against the motion
Gambacorta, M. A.
RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S858 - S859
[7] COST-EFFECTIVENESS OF APIXABAN AGAINST CURRENT STANDARD OF CARE FOR STROKE PREVENTION IN ATRIAL FIBRILLATION IN CHILE
Vallejos, C.
Lanas Zanetti, F.
Castro, C.
Bustos, L.
VALUE IN HEALTH, 2014, 17 (03) : A117 - A117
[8] Cost-effectiveness of apixaban against current standard of care (SoC) for stroke prevention in atrial fibrillation patients
Dorian, P.
Kongnakorn, T.
Phatak, H.
Rublee, D.
Kuznik, A.
Lanitis, T.
Liu, L.
Iloeje, U.
Lip, G. Y. H.
EUROPEAN HEART JOURNAL, 2012, 33 : 969 - 969
[9] Efficacy of teclistamab against the current standard of care in patients with triple-exposed relapsed/refractory multiple myeloma (RRMM) in=3 lines of therapy: Comparison with clinical practice data in the LocoMMotion study
Weisel, K.
van de Donk, Wcj N.
Moreau, P.
Delforge, M.
Einsele, H.
Ghilotti, F.
Diels, J.
Elsada, A.
Strulev, V
Pei, L.
Kobos, R.
Smit, J.
Slavcev, M.
Mateos, M. -, V
ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 304 - 304

← 1 →